Skip Navigation

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Olopade, O. I.
Right arrow Articles by Pichert, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Olopade, O. I.
Right arrow Articles by Pichert, G.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 12:895-908, 2001
© 2001 European Society for Medical Oncology

review-article

Cancer genetics in oncology practice

O. I. Olopade1, and G. Pichert2

1University of Chicago Pritzker School of Medicine Chicago, Illinois, USA
2Department of Medicine, University Hospital Zurich, Switzerland

O.L. Olopade, MD Section of Hematology/Oncology Center for Clinical Cancer Genetics University of Chicago MC2115. 5841 S. Maryland Ave Chicago, IL 60637 USA E-mail folopade{at}medicine.bsd.uchicago.edu

Cancer is a genetic disease caused by the progressive accumulation of mutations in critical genes that control cell growth and differentiation. Completion of the Human Genome Project promises to revolutionize the practice of Medicine, especially Oncology care. The tremendous gains in the knowledge of the structure and function of human genes will surely impact the diagnosis, prognosis and treatment of cancer. Moreover, it will lead to more effective cancer control through the use of genetics to quantify individual cancer risks. This article reviews the current status of genetic testing and counseling for cancer risk assessment and will suggest a framework for integrating such counseling into oncology practice.

BRCA1, BRCA2, cancer genetics, cancer screening, familial risks, FAP, genetic counseling, HNPCC, prevention


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
Y.-s. Zhao, D. Pang, F. Wang, Y.-w. Xue, D.-n. Gao, H. Li, K. Li, B.-y. Wang, D. Wang, and H.-y. Li
Nipple Aspirate Fluid Collection, Related Factors and Relationship between Carcinoembryonic Antigen in Nipple Aspirate Fluid and Breast Diseases in Women in Harbin, PRC
Cancer Epidemiol. Biomarkers Prev., March 1, 2009; 18(3): 732 - 738.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
A. Contegiacomo, M. Pensabene, I. Capuano, L. Tauchmanova, M. Federico, D. Turchetti, L. Cortesi, P. Marchetti, E. Ricevuto, G. Cianci, et al.
An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer
Ann. Onc., May 1, 2004; 15(5): 726 - 732.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.